TI
ACOR

Trexquant Investment’s Acorda Therapeutics ACOR Stock Holding History

Trexquant Investment’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-400
Closed -$747K – 1402
2018
Q4 		$747K Buy
+400
New +$870K 0.05% 508
2018
Q3 		– Sell
-97
Closed -$332K – 1264
2018
Q2 		$332K Sell
97
-145
-60% -$444K 0.02% 649
2018
Q1 		$686K Buy
+242
New +$725K 0.05% 531
2016
Q2 		– Sell
-490
Closed -$1.56M – 1170
2016
Q1 		$1.56M Buy
490
+378
+338% +$1.57M 0.18% 180
2015
Q4 		$574K Sell
112
-406
-78% -$1.77M 0.05% 629
2015
Q3 		$1.65M Buy
+518
New +$2.01M 0.14% 219
2015
Q2 		– Sell
-430
Closed -$1.72M – 1307
2015
Q1 		$1.72M Buy
+430
New +$1.97M 0.18% 155

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Trexquant Investment's ACOR Position: Q1 2019 in Review

Trexquant Investment sold out of Acorda Therapeutics (ACOR) in Q1 2019, closing a stake of 400 shares — an estimated $747K sold.

Trexquant Investment first reported a position in ACOR in Q1 2015 and held it in 7 quarters. The position peaked at $1.72M in Q1 2015. 184 funds tracked by Wall St. Rank hold ACOR as of Q1 2019.

  • Trexquant Investment reported no remaining Acorda Therapeutics position as of Q1 2019 after selling out during the quarter.
  • Trexquant Investment sold 400 Acorda Therapeutics shares in Q1 2019, an estimated $747K.
  • Trexquant Investment first reported a position in Acorda Therapeutics in Q1 2015 and held it in 7 quarters.
  • Trexquant Investment's Acorda Therapeutics position peaked at $1.72M in Q1 2015.
  • 184 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2019.

Based on Trexquant Investment's 13F filing for Q1 2019, filed 13 May 2019.